NTC-2-VDJ
Mus musculus
source_name
Tumor
tissue
Tumor
cell line
B16-OVA-Cas9 melanoma
cell type
CD45+ immune cells and B16-OVA cells
genotype
NTC
treatment
CD45+ immune cells and tumor cells from B16-OVA-Cas9-sgNTC tumors (TCR)
geo_loc_name
missing
collection_date
missing